According to Lycopodium's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 7.96128. At the end of 2023 the company had a P/E ratio of 8.33.
Year | P/E ratio | Change |
---|---|---|
2023 | 8.33 | 10.47% |
2022 | 7.54 | -40.05% |
2021 | 12.6 | -13.5% |
2020 | 14.5 | 38.41% |
2019 | 10.5 | 22.34% |
2018 | 8.59 | -13.15% |
2017 | 9.89 | -54.75% |
2016 | 21.9 | -148.22% |
2015 | -45.3 | -433.19% |
2014 | 13.6 | 163.27% |
2013 | 5.17 | -27.24% |
2012 | 7.10 | -5.55% |
2011 | 7.52 | 32.44% |
2010 | 5.68 | 99.97% |
2009 | 2.84 | -68.77% |
2008 | 9.09 | -20.34% |
2007 | 11.4 | 1.5% |
2006 | 11.2 | 34.89% |
2005 | 8.34 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.